Liver surgery combo fails to show clear survival edge in advanced colorectal cancer
NCT ID NCT02738606
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether removing liver tumors with surgery, along with chemotherapy, helps people with colorectal cancer that has spread to the liver and lungs live longer compared to chemotherapy alone. The trial was stopped early after enrolling only 29 participants. The results did not show a clear survival benefit from adding surgery, so the best approach remains uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new blood test spot colorectal cancer return earlier?
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Experimental drug combo targets Hard-to-Treat GI cancers
- Double immunotherapy plus liver blockade targets eye cancer that spreads
- Could a pill help the liver regrow and make more cancer surgeries possible?
- Experimental combo targets Hard-to-Treat GI cancers